Updates

April 17, 2019
AstraZeneca Teams with Daiichi Sankyo to Speed Development of HER2-positive Advanced Breast Cancer Therapy

AstraZeneca is starting a collaboration with Daiichi Sankyo for the global production and commercialization of trastuzumab deruxtecan (DS-8201), a novel antibody-drug conjugate under clinical studies ... Read more
April 16, 2019April 15, 2019
It’s Probably Nothing

It’s probably not back. But if it is, it’ll kill me. Every six months, I travel to the Bay Area for tests to see ... Read more
April 15, 2019
Lynparza Approved in EU to Treat Subset of Advanced Breast Cancer

Lynparza (olaparib) tablets have been approved by the European Commission as a standalone treatment for adults with a subset of locally advanced or metastatic ... Read more
April 12, 2019
Surgery Extends Lives of Women with Metastatic Breast Cancer, Study Says

Women with HER2-positive breast cancer that has spread to distant organs live longer if they have surgery to remove their primary tumor, according ... Read more
April 10, 2019
FDA Approves Ibrance Combo Therapy for Some Male Breast Cancers

The U.S. Food and Drug Administration (FDA) has expanded the use of Ibrance (palbociclib) capsules in combination with an aromatase inhibitor or Faslodex (fulvestrant) to ... Read more

News

Time-Restricted Feeding May Cut Tumor Risk in Obese Women, Mouse Study Suggests
April 8, 2019
A preliminary study in mice suggests that when a person eats, and not what ...
News

Faslodex-Arimidex Improves Survival in Post-menopausal Women with Advanced BC, Trial Shows
April 5, 2019
First-line treatment with Arimidex (anastrozole) plus Faslodex (fulvestrant) prolongs the lives of post-menopausal women ...
News

FDA Proposes New Policies to Modernize, Improve Quality of Mammography Screenings
April 3, 2019
The U.S. Food and Drug Administration (FDA) has proposed a set of new policies ...
A Lump in the Road - A Column by Nancy Brier, Columns

Doc, You’re a Downer. Let Me Revel in My 5-Year Mark
April 2, 2019March 29, 2019
I met a guy at a party. At first, he was quite the charmer, ...
News

Breast Cancer Survivors Weigh in on Ways to Reduce the Financial Burden of the Disease
April 1, 2019
A qualitative study has proposed nine recommendations from breast cancer survivors about how to ...
News

Frying Oil Reheated Often, Like in Deep Frying, Seen to Promote Breast Cancer’s Spread in Animal Study
March 29, 2019
Frying oil that has repeatedly been reheated to high temperatures — as can take ...

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

Molecular Patterns of Breast Cancer May Predict Chance of Relapse Up to 20 Years Later
March 27, 2019
Screening a woman’s breast cancer for certain genetic and molecular patterns may be used ...
Estrogen May Trigger Brain Metastasis in Triple-negative Breast Cancer, Study Shows
March 25, 2019
Estradiol, a type of estrogen and the major female hormone, may drive the spread ...
AI Matches Radiologists’ Skill at Detecting Breast Cancer on Mammograms
March 22, 2019
CHMP Favors EU Approval of Lynparza for Some Advanced Breast Cancers
March 20, 2019
Reaching the Double Nickel
March 19, 2019March 18, 2019
Vitamin C Might Reverse Stress-induced Driver of Breast Cancer, Study Says
March 18, 2019

FDA Grants Accelerated Approval to Tecentriq-Abraxane Combo for Some TNBC
March 15, 2019
The U.S. Food and Drug Administration has granted accelerated approval to a combination of ...
Thousands of Lives Spared Thanks to Screening, Treatment, Study Reports
March 13, 2019
NeuVax/Herceptin Combo Promotes Disease-free Survival in TNBC
March 11, 2019
FDA Approves Under-the-skin Formulation of Herceptin for Certain Breast Cancers
March 8, 2019

Imaging Agent May Provide Early Info About Benefits of Hormone Therapies for Breast Cancer
March 6, 2019
A new imaging agent that successfully measures changes in progesterone receptor (PR) levels may ...
How to Tell Your Kid You Have Cancer: 7 Tips
March 5, 2019March 4, 2019
Cellular Barcoding Sheds Light on Spread, Drug Resistance of TNBC
March 4, 2019

News

Pfizer’s Biosimilar Zirabev Approved in E.U. for Advanced Breast, Other Cancers
March 1, 2019
Metastatic breast cancer patients in the European Union will have the possibility of being ...
News

Sacituzumab Govitecan Shinks Tumors in One of Three Metastatic TNBC Patients, Trial Shows
February 27, 2019
One in three women with metastatic triple-negative breast cancer — all of whom had received ...
A Lump in the Road - A Column by Nancy Brier, Columns

Fingers on My Breasts and Questions on My Mind
February 26, 2019February 22, 2019
While my doctor’s fingers massaged my breasts and cradled my hard, almond-sized lump, we ...
News

More Intense Chemotherapy May Lower Risk of Breast Cancer Recurrence and Death, Study Says
February 25, 2019
Reducing the interval between chemotherapy treatment cycles or administering chemotherapy medications sequentially at higher ...
News

Plerixafor Improves Immunotherapy Response in Mouse Model of Breast Cancer
February 22, 2019
Plerixafor — approved for the treatment of lymphoma and multiple myeloma — decreases tumor fibrosis ...
News

Young Survival Coalition Hosts Summit for BC Survivors, Supporters
February 18, 2019
More than 600 young breast cancer survivors will gather in Austin, Texas, for the ...
News

Experimental Compound Could Broaden HER2-targeted Approach to BC
February 15, 2019February 18, 2019
By targeting small regulatory molecules called microRNAs (miRNAs), researchers were able to reprogram breast cancer cells ...
News

Changes in Gene Expression May Hint at Relapse Risk in ER-positive Patients on Hormone Therapy, Study Finds
February 13, 2019
Specific changes in gene expression might help to predict the risk of relapse in ...
A Lump in the Road - A Column by Nancy Brier, Columns

The Luck of the Draw
February 12, 2019February 8, 2019
Through the unlikeliest of circumstances, I found myself in a first-class seat on a ...
News

Margetuximab Helps to Delay Disease Progression in Advanced, HER2-positive Breast Cancers, Phase 3 Trial Shows
February 11, 2019
A combination of MacroGenics‘ HER2 antibody margetuximab and standard chemotherapy is superior to Herceptin (trastuzumab) plus chemotherapy ...
News

FDA to Review Kadcyla for Certain HER2-positive Early-stage Breast Cancer Patients
February 8, 2019
The U.S. Food and Drug Administration is reviewing Kadcyla (trastuzumab emtansine) as a post-surgery treatment for ...
News

Knight Therapeutics Acquires Exclusive Marketing Rights to Nerlynx in Canada
February 6, 2019
Breast cancer treatment Nerlynx (neratinib) will be exclusively commercialized in Canada by Knight Therapeutics, under ...
News

Breast Cancers Diagnosed Within 10 Years of Pregnancy Have Higher Risk of Metastasis, Study Shows
February 4, 2019
Women diagnosed with breast cancer up to 10 years after giving birth have a ...
News

Blocking Interaction Between Blood Vessels, Cancer Cells Could Prevent Disease’s Spread, Study Says
February 1, 2019
Blocking the interaction between cancer cells and their microenvironment could be a viable strategy ...
News

Mathematical Model Calculates Breast Cancer Risk in Women
January 30, 2019
Researchers developed a mathematical model to calculate breast cancer risk in women, based on ...
A Lump in the Road - A Column by Nancy Brier, Columns

Teaching an Old Drug New Tricks: Ketamine and Depression
January 29, 2019January 29, 2019
“No fresh flowers,” my doctor said. “Avoid salad. No uncooked food. And don’t bring ...
News

Breast Cancer Cells Can Be Turned into Harmless Fat Cells in Mice, Study Shows
January 28, 2019
With the right molecular cues, breast cancer cells can be converted into harmless fat ...
News

FDA Wants More Data Before Sacituzumab Govitecan Is Approved for Metastatic Triple-negative Breast Cancer
January 25, 2019
The U.S. Food and Drug Administration (FDA) has rejected Immunomedics’ application for accelerated approval ...

June 22, 2018June 22, 2018

Clinical Trial of Tamoxifen-based Gel in Reducing Breast Density Recruiting in US, EU

News

The ability of a gel containing a tamoxifen-byproduct to reduce breast density — associated with an increased risk of breast cancer — is now being evaluated in a recruiting Phase 3 clinical trial. Approximately half of women in ... Read more

Pin It on Pinterest